| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |